Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Oncology|October 22, 1998
Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancerS Culine, J Kattan, S Zanetta, et al.
Minerva Pediatrica|November 6, 2007
[Polyuria and polydipsia in a 5 year-old child: diagnostic problems]G Di Dio, F Zanetta, S Zanetta, et al.
Investigational New Drugs|April 12, 2000
A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokineticsC J Ardiet, B Tranchand, S Zanetta, et al.
Journal of Endocrinological Investigation|February 10, 2018
Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak timeM Castagno, A Monzani, S Zanetta, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2013
[Reirradiations of head and neck cancers: state of the concept and ways of development]B Soltys, N Wiazzane, C Mirjolet, et al.
Minerva Pediatrica|February 21, 2013
Epistaxis in children under the age of two: possible marker of abuse/neglect? A retrospective study in North-Eastern Piedmont hospitalsL Boscardini, S Zanetta, G Ballardini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)C Terret, S Zanetta, H Roché, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot studyN Isambert, M Correia, J P Cercueil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humansA Santos, S Zanetta, T Cresteil, et al.
Annales De Biologie Clinique|April 9, 2002
[Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]J M Riedinger, N Eche, J P Basuyau, et al.
Pageof 2